{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:44:53Z","timestamp":1783421093917,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jbo.2025.100661","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:26:00Z","timestamp":1738110360000},"page":"100661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva\u00ae) in patients with bone metastasis from solid tumors"],"prefix":"10.1016","volume":"51","author":[{"given":"Mingchuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2982-6532","authenticated-orcid":false,"given":"Pengpeng","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2025.100661_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2019.10.012","article-title":"Marie-H\u00e9l\u00e8ne Vieillard. Bone Metastasis: Current State of Play.[J]","author":"Turpin","year":"2020","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jbo.2025.100661_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO Clinical Practice Guidelines[J]","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jbo.2025.100661_b0015","doi-asserted-by":"crossref","unstructured":"Moos R V , Costa L , Gonzalez-Suarez E ,et al.Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody[J].Cancer treatment reviews, 2019, 76:57-67.DOI:10.1016\/j.ctrv.2019.05.003.","DOI":"10.1016\/j.ctrv.2019.05.003"},{"key":"10.1016\/j.jbo.2025.100661_b0020","doi-asserted-by":"crossref","unstructured":"D'Oronzo S , Coleman R , Brown J ,et al.Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management[J].Journal of Bone Oncology, 2019, 15.DOI:10.1016\/j.jbo.2018.10.004.","DOI":"10.1016\/j.jbo.2018.10.004"},{"issue":"1","key":"10.1016\/j.jbo.2025.100661_b0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1346.020","article-title":"Molecular mechanism of the life and death of the osteoclast[J]","volume":"1068","author":"Tanaka","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jbo.2025.100661_b0030","unstructured":"Amgen. XGEVA\u00ae (denosumab) U.S. Prescribing Information. [Accessed in Feb 2023]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=628f0998-1206-4001-aeee-18133aa9f3bf."},{"key":"10.1016\/j.jbo.2025.100661_b0035","unstructured":"Amgen. XGEVA\u00ae (denosumab) CHN Prescribing Information. [Accessed in Feb 2023]. Available from: http:\/\/www.mijian360.com\/drugs\/55-Denosumab.html."},{"key":"10.1016\/j.jbo.2025.100661_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100499","article-title":"A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva\u00ae) in healthy Chinese subjects[J]","volume":"42","author":"Ding","year":"2023","journal-title":"Journal of Bone Oncology"},{"key":"10.1016\/j.jbo.2025.100661_b0045","unstructured":"CHN National Medical Products Administration. Guidelines for Clinical Trials of Biosimilars of Dessumab Injection (Malignant Tumor Indication) (Draft for Comments). https:\/\/www.cde.org.cn\/zdyz\/opinioninfopage?zdyzIdCODE=54d152facd1710b66e2920f24c648c55."},{"issue":"2","key":"10.1016\/j.jbo.2025.100661_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/17530050903473147","article-title":"Biomarkers of bone turnover in oncology: applications in diagnosis and treatment[J]","volume":"4","author":"Brown","year":"2010","journal-title":"Expert Opin Med Diagn"},{"issue":"4","key":"10.1016\/j.jbo.2025.100661_b0055","first-page":"333","article-title":"Molecular basis and clinical application of biological markers of bone turnover[J]","volume":"17","author":"Calvo","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jbo.2025.100661_b0060","unstructured":"Shang H, Wang LL. Laboratory Diagnostics. Third Edition [M]. People\u2019s Medical Publishing House, 2015."},{"issue":"22","key":"10.1016\/j.jbo.2025.100661_b0065","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1200\/JCO.2005.06.091","article-title":"Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. [J]","volume":"23","author":"Coleman","year":"2005","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jbo.2025.100661_b0070","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.[J]","volume":"94","author":"Saad","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jbo.2025.100661_b0075","article-title":"Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.[J]. Journal of Clinical Oncology Official Journal of the American Society of","volume":"25(28):4431","author":"Lipton","year":"2007","journal-title":"Clin Oncol"},{"issue":"10","key":"10.1016\/j.jbo.2025.100661_b0080","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates [J]","volume":"27","author":"Fizazi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jbo.2025.100661_b0085","unstructured":"U.S. Food and Drug Administration. Guidance for Industry: Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product [EB\/OL]. (2016-12-29). https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm397017.pdf."},{"key":"10.1016\/j.jbo.2025.100661_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100499","article-title":"A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva\u00ae) in healthy Chinese subjects[J]","volume":"42","author":"Ding","year":"2023","journal-title":"Journal of Bone Oncology"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:20:10Z","timestamp":1742390410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137425000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":18,"alternative-id":["S2212137425000028"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100661","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva\u00ae) in patients with bone metastasis from solid tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100661"}}